Clinical, epidemiological, and microbiological profile of patients with vancomycin-resistant Enterococci from a Tertiary Care Hospital

Journal of Global Infectious Diseases

Volumn 4, Issue 2, 2012, Pages 137-138

  Vidyalakshmi, P R ^a   Gopalakrishnan, R ^a   Ramasubramanian, V ^a   Ghafur, K ^a   Nambi, P ^a   Thirunarayana, M ^a  

^a APOLLO HOSPITALS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; DAPTOMYCIN; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CLINICAL ASSESSMENT; COMORBIDITY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIOLOGY; EUROPE; GRAM POSITIVE BACTERIUM; HUMAN; INDIA; LETTER; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NORTH AMERICA; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TERTIARY HEALTH CARE; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84862518965     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.96784     Document Type: Letter

References (7)

1. Gopalakrishnan R, Sureshkumar D. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India 2010;58 SUPPL.:25-31.
2. Performance standards for antimicrobial susceptibility testing; CLSI twenty first informational SUPPL.ement M100-S21;Vol. 31 No.1. 2011.
3. Mathai D, Biedenbach DJ, Jones RN, Bell JM, Turnidge J, Sader HS. India Daptomycin Study Group. Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007). Int J Antimicrob Agents 2009;34:497-9.
4. Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, et al. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study. Clin Ther 2010;32:1713-9.
5. Dhawan B, Gadepalli R, Kapil A. In vitro activity of daptomycin against Staphylococcus aureus and Vancomycin resistant enterococcus faecium isolates associated with skin and soft tissue infections: First results from India. Diagn Microbiol Infect Dis 2009;65:196-8.
6. Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, et al. Genetic basis for in vivo daptomycin resistance in Enterococci. N Engl J Med 2011;365:892-900.
7. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ. Surveillance of multidrug resistant organisms in a tertiary care hospital in Delhi, India. J Assoc Physicians India 2010;58 SUPPL.:32-6.